Zurich Cantonal Bank
INSY

Zurich Cantonal Bank’s Insys Therapeutics, Inc. INSY Stock Holding History

Zurich Cantonal Bank’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,793
Closed -$8K – 2655
2019
Q1 		$8K Hold
1,793
– – ﹤0.01% 2536
2018
Q4 		$6K Hold
1,793
– – ﹤0.01% 2573
2018
Q3 		$18K Hold
1,793
– – ﹤0.01% 2495
2018
Q2 		$13K Sell
1,793
-3,037
-63% -$21.2K ﹤0.01% 2474
2018
Q1 		$29K Buy
4,830
+4,133
+593% +$34.1K ﹤0.01% 2317
2017
Q4 		$7K Hold
697
– – ﹤0.01% 2523
2017
Q3 		$6K Hold
697
– – ﹤0.01% 2489
2017
Q2 		$9K Hold
697
– – ﹤0.01% 2454
2017
Q1 		$7K Hold
697
– – ﹤0.01% 2542
2016
Q4 		$6K Hold
697
– – ﹤0.01% 2520
2016
Q3 		$8K Hold
697
– – ﹤0.01% 2463
2016
Q2 		$9K Hold
697
– – ﹤0.01% 2412
2016
Q1 		$11K Hold
697
– – ﹤0.01% 2343
2015
Q4 		$20K Buy
697
+422
+153% +$11.7K ﹤0.01% 2100
2015
Q3 		$8K Buy
+275
New +$10.1K ﹤0.01% 2256

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Zurich Cantonal Bank's INSY Position: Q2 2019 in Review

Zurich Cantonal Bank sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 1,793 shares — an estimated $8K sold.

Zurich Cantonal Bank first reported a position in INSY in Q3 2015 and held it in 15 quarters. The position peaked at $29K in Q1 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Zurich Cantonal Bank reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,793 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $8K.
  • Zurich Cantonal Bank first reported a position in Insys Therapeutics, Inc. in Q3 2015 and held it in 15 quarters.
  • Zurich Cantonal Bank's Insys Therapeutics, Inc. position peaked at $29K in Q1 2018.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Zurich Cantonal Bank's 13F filing for Q2 2019, filed 30 Jul 2019.